When Elon Musk started Neuralink in 2016, he tapped leading neurosurgeon Ben Rapoport to join as a co-founder. But two years later, citing safety and scalability concerns, Rapoport left to co-found a rival company: Precision Neuroscience. Today, we speak with his co-founder, Michael Mager, about what sets Precision apart, the future of brain–computer interfaces (BCIs), and what Precision has already been able to achieve with over 70 implanted patients. Learn more about your ad choices. Visit podcastchoices.com/adchoices
Fler avsnitt av Solutions with Henry Blodget
Visa alla avsnitt av Solutions with Henry BlodgetSolutions with Henry Blodget med Vox Media Podcast Network finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
